Annual Accounts Payable
$120.50 K
-$63.30 K-34.44%
December 31, 2023
Summary
- As of February 21, 2025, LIXT annual accounts payable is $120.50 thousand, with the most recent change of -$63.30 thousand (-34.44%) on December 31, 2023.
- During the last 3 years, LIXT annual accounts payable has fallen by -$69.80 thousand (-36.68%).
- LIXT annual accounts payable is now -61.38% below its all-time high of $312.00 thousand, reached on December 31, 2017.
Performance
LIXT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
N/A
September 30, 2024
Summary
- LIXT quarterly accounts payable is not available.
Performance
LIXT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
LIXT Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -34.4% | - |
3 y3 years | -36.7% | - |
5 y5 years | - | - |
LIXT Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -34.4% | at low | ||
5 y | 5-year | -36.7% | at low | ||
alltime | all time | -61.4% | +725.3% |
Lixte Biotechnology Holdings Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $120.50 K(-34.4%) | $120.50 K(-34.4%) |
Dec 2022 | $183.80 K(-3.4%) | $183.80 K(-20.8%) |
Sep 2021 | - | $232.00 K(+42.9%) |
Jun 2021 | - | $162.40 K(+9.1%) |
Mar 2021 | - | $148.90 K(-21.8%) |
Dec 2020 | $190.30 K(+32.6%) | $190.30 K(+64.8%) |
Sep 2020 | - | $115.50 K(-39.2%) |
Jun 2020 | - | $189.90 K(+18.0%) |
Mar 2020 | - | $160.90 K(+12.1%) |
Dec 2019 | $143.50 K(-54.0%) | $143.50 K(-47.5%) |
Sep 2019 | - | $273.50 K(+48.7%) |
Jun 2019 | - | $183.90 K(-12.7%) |
Mar 2019 | - | $210.70 K(-46.9%) |
Sep 2018 | - | $396.60 K(+43.7%) |
Jun 2018 | - | $275.90 K(+46.4%) |
Mar 2018 | - | $188.50 K(-39.6%) |
Dec 2017 | $312.00 K(+95.5%) | $312.00 K(+91.2%) |
Sep 2017 | - | $163.20 K(-18.8%) |
Jun 2017 | - | $201.10 K(-5.2%) |
Mar 2017 | - | $212.20 K(+33.0%) |
Dec 2016 | $159.60 K(+0.3%) | $159.60 K(+42.4%) |
Sep 2016 | - | $112.10 K(+44.6%) |
Jun 2016 | - | $77.50 K(-7.1%) |
Mar 2016 | - | $83.40 K(-47.6%) |
Dec 2015 | $159.10 K(+29.9%) | $159.10 K(+31.3%) |
Sep 2015 | - | $121.20 K(+55.4%) |
Jun 2015 | - | $78.00 K(-29.1%) |
Mar 2015 | - | $110.00 K(-10.2%) |
Dec 2014 | $122.50 K | $122.50 K(-6.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2014 | - | $130.50 K(+17.5%) |
Jun 2014 | - | $111.10 K(+37.2%) |
Mar 2014 | - | $81.00 K(-24.9%) |
Dec 2013 | $107.80 K(+34.1%) | $107.80 K(+66.9%) |
Sep 2013 | - | $64.60 K(-2.1%) |
Jun 2013 | - | $66.00 K(-9.5%) |
Mar 2013 | - | $72.90 K(-9.3%) |
Dec 2012 | $80.40 K(-26.4%) | $80.40 K(-42.9%) |
Sep 2012 | - | $140.70 K(-13.7%) |
Jun 2012 | - | $163.10 K(+1.2%) |
Mar 2012 | - | $161.20 K(+47.5%) |
Dec 2011 | $109.30 K(+6.8%) | $109.30 K(-29.5%) |
Sep 2011 | - | $155.10 K(+0.2%) |
Jun 2011 | - | $154.80 K(+51.3%) |
Dec 2010 | $102.30 K(+38.8%) | $102.30 K(+10.4%) |
Sep 2009 | - | $92.70 K(0.0%) |
Mar 2009 | - | $92.70 K(-8.2%) |
Sep 2008 | - | $101.00 K(+109.5%) |
Jun 2008 | - | $48.20 K(-26.5%) |
Mar 2008 | - | $65.60 K(-11.0%) |
Dec 2007 | $73.70 K(+131.8%) | $73.70 K(+94.5%) |
Sep 2007 | - | $37.90 K(+226.7%) |
Jun 2007 | - | $11.60 K(-83.2%) |
Mar 2007 | - | $68.90 K(+116.7%) |
Dec 2006 | $31.80 K(+117.8%) | $31.80 K(+84.9%) |
Sep 2006 | - | $17.20 K(-43.8%) |
Jun 2006 | - | $30.60 K(+7550.0%) |
Mar 2006 | - | $400.00 |
Dec 2005 | $14.60 K | - |
FAQ
- What is Lixte Biotechnology Holdings annual accounts payable?
- What is the all time high annual accounts payable for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings annual accounts payable year-on-year change?
- What is the all time high quarterly accounts payable for Lixte Biotechnology Holdings?
What is Lixte Biotechnology Holdings annual accounts payable?
The current annual accounts payable of LIXT is $120.50 K
What is the all time high annual accounts payable for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high annual accounts payable is $312.00 K
What is Lixte Biotechnology Holdings annual accounts payable year-on-year change?
Over the past year, LIXT annual accounts payable has changed by -$63.30 K (-34.44%)
What is the all time high quarterly accounts payable for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high quarterly accounts payable is $396.60 K